Adipose tissue natriuretic peptide receptor expression is related to insulin sensitivity in obesity and diabetes

Obesity

Volumn 24, Issue 4, 2016, Pages 820-828

  Kovacova, Zuzana ^a   Tharp, William G ^b   Liu, Dianxin ^c   Wei, Wan ^c   Xie, Hui ^a   Collins, Sheila ^c   Pratley, Richard E ^a,c  

^a FLORIDA HOSPITAL   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c BURNHAM INSTITUTE   (United States)

Author keywords

adipose tissue; natriuretic peptide receptors; obesity; type 2 diabetes mellitus

Indexed keywords

GLUCOSE; INSULIN; MESSENGER RNA; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE RECEPTOR C; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; PLACEBO; UNCOUPLING PROTEIN 1; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; ATRIAL NATRIURETIC FACTOR RECEPTOR;

ADIPOSE TISSUE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; MALE; MUSCLE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; THERMOGENESIS; TISSUE LEVEL; ADULT; DIABETES MELLITUS, TYPE 2; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; RECEPTORS, ATRIAL NATRIURETIC FACTOR; THIAZOLIDINEDIONES;

EID: 84962071134     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21418     Document Type: Article

References (33)

1. Pandey KN., Guanylyl cyclase/atrial natriuretic peptide receptor-A: role in the pathophysiology of cardiovascular regulation. Can J Physiol Pharmacol 2011; 89: 557-573.
2. Potter LR, Abbey-Hosch S, Dickey DM., Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 2006; 27: 47-72.
3. Potter LR, Hunter T., Guanylyl cyclase-linked natriuretic peptide receptors: structure and regulation. J Biol Chem 2001; 276: 6057-6060.
4. Lafontan M, Moro C, Berlan M, Crampes F, Sengenes C, Galitzky J., Control of lipolysis by natriuretic peptides and cyclic GMP. Trends Endocrinol Metab 2008; 19: 130-137.
5. Potter LR., Natriuretic peptide metabolism, clearance and degradation. FEBS J 2011; 278: 1808-1817.
6. Collins S., A heart-adipose tissue connection in the regulation of energy metabolism. Nat Rev Endocrinol 2014; 10: 157-163.
7. Nakatsuji H, Maeda N, Hibuse T, et al., Reciprocal regulation of natriuretic peptide receptors by insulin in adipose cells. Biochem Biophys Res Commun 2010; 392: 100-105.
8. Sarzani R, Paci VM, Dessi-Fulgheri P, Espinosa E, Rappelli A., Comparative analysis of atrial natriuretic peptide receptor expression in rat tissues. J Hypertens Suppl 1993; 11: S214-S215.
9. Sarzani R, Dessi-Fulgheri P, Paci VM, Espinosa E, Rappelli A., Expression of natriuretic peptide receptors in human adipose and other tissues. J Endocrinol Invest 1996; 19: 581-585.
10. Sengenes C, Berlan M, De Glisezinski I, Lafontan M, Galitzky J., Natriuretic peptides: a new lipolytic pathway in human adipocytes. FASEB J 2000; 14: 1345-1351.
11. Buglioni A, Cannone V, Cataliotti A, et al., Circulating aldosterone and natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease. Hypertension 2015; 65: 45-53.
12. Miyashita K, Itoh H, Tsujimoto H, et al., Natriuretic peptides/cGMP/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity. Diabetes 2009; 58: 2880-2892.
13. Wang TJ, Larson MG, Levy D, et al., Impact of obesity on plasma natriuretic peptide levels. Circulation 2004; 109: 594-600.
14. Wang TJ, Larson MG, Keyes MJ, Levy D, Benjamin EJ, Vasan RS., Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals. Circulation 2007; 115: 1345-1353.
15. Bordicchia M, Liu D, Amri EZ, et al., Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. J Clin Invest 2012; 122: 1022-1036.
16. Engeli S, Birkenfeld AL, Badin PM, et al., Natriuretic peptides enhance the oxidative capacity of human skeletal muscle. J Clin Invest 2012; 122: 4675-4679.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC., Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
18. Katz A, Nambi SS, Mather K, et al., Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402-2410.
19. Pacini G, Bergman RN., MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 1986; 23: 113-122.
20. Lin J, Handschin C, Spiegelman BM., Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 2005; 1: 361-370.
21. Fonseca V., Effect of thiazolidinediones on body weight in patients with diabetes mellitus. Am J Med 2003; 115 (Suppl 8A): 42S-48S.
22. Birkenfeld AL, Boschmann M, Moro C, et al., Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans. J Clin Endocrinol Metab 2005; 90: 3622-3628.
23. Birkenfeld AL, Budziarek P, Boschmann M, et al., Atrial natriuretic peptide induces postprandial lipid oxidation in humans. Diabetes 2008; 57: 3199-3204.
24. Semple RK, Crowley VC, Sewter CP, et al., Expression of the thermogenic nuclear hormone receptor coactivator PGC-1α is reduced in the adipose tissue of morbidly obese subjects. Int J Obes Relat Metab Disord 2004; 28: 176-179.
25. Ruschke K, Fishbein L, Dietrich A, et al., Gene expression of PPARγ and PGC-1α in human omental and subcutaneous adipose tissues is related to insulin resistance markers and mediates beneficial effects of physical training. Eur J Endocrinol 2010; 162: 515-523.
26. Pivovarova O, Gogebakan O, Kloting N, et al., Insulin up-regulates natriuretic peptide clearance receptor expression in the subcutaneous fat depot in obese subjects: a missing link between CVD risk and obesity? J Clin Endocrinol Metab 2012; 97: E731-E739.
27. Dessi-Fulgheri P, Sarzani R, Rappelli A., The natriuretic peptide system in obesity-related hypertension: new pathophysiological aspects. J Nephrol 1998; 11: 296-299.
28. Sarzani R, Salvi F, Dessi-Fulgheri P, Rappelli A., Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J Hypertens 2008; 26: 831-843.
29. Matsukawa N, Grzesik WJ, Takahashi N, et al., The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc Natl Acad Sci USA 1999; 96: 7403-7408.
30. Cinti S., The adipose organ at a glance. Dis Model Mech 2012; 5: 588-594.
31. Cohen P, Levy JD, Zhang Y, et al., Ablation of PRDM16 and beige adipose causes metabolic dysfunction and a subcutaneous to visceral fat switch. Cell 2014; 156: 304-316.
32. Barbatelli G, Murano I, Madsen L, et al., The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation. Am J Physiol Endocrinol Metab 2010; 298: E1244-E1253.
33. Fisher FM, Kleiner S, Douris N, et al., FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis. Genes Dev 2012; 26: 271-281.